ContraFect ROA 2014-2018 | CFRX

Current and historical return on assets (ROA) values for ContraFect (CFRX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. ContraFect ROA for the three months ending September 30, 2018 was -72.45%.
ContraFect ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $-0.05B $0.04B -112.28%
2018-06-30 $-0.05B $0.04B -99.46%
2018-03-31 $-0.03B $0.04B -67.05%
2017-12-31 $-0.02B $0.05B -39.51%
2017-09-30 $-0.01B $0.06B -26.67%
2017-06-30 $-0.02B $0.03B -53.90%
2017-03-31 $-0.03B $0.03B -75.36%
2016-12-31 $-0.03B $0.04B -85.93%
2016-09-30 $-0.04B $0.05B -114.29%
2016-06-30 $-0.03B $0.02B -110.92%
2016-03-31 $-0.03B $0.03B -88.89%
2015-12-31 $-0.03B $0.04B -79.39%
2015-09-30 $-0.02B $0.03B -73.60%
2015-06-30 $-0.03B $0.04B -103.94%
2015-03-31 $-0.03B $0.03B -140.21%
2014-12-31 $-0.03B $0.03B -188.89%
2014-09-30 $-0.03B $0.03B -276.19%
2014-06-30 $-0.02B $0.01B -850.00%
2014-03-31 $-0.01B $0.00B inf%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.164B $0.000B
ContraFect Corporation is a biotechnology company. The Company is focused on protein and antibody therapeutic products for life-threatening infectious diseases. Its product candidates are CF-301, a lysin for the treatment of Staph aureus bacteremia, and CF-404, a combination of mAbs for the treatment of life-threatening seasonal and pandemic varieties of influenza. ContraFect Corporation is headquartered in Yonkers, New York.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $52.655B 11.23
Zoetis (ZTS) United States $43.591B 29.84
Grifols (GRFS) Spain $13.131B 16.02
Jazz Pharmaceuticals (JAZZ) Ireland $8.494B 12.19
Tilray (TLRY) United States $7.871B 0.00
Ionis Pharmaceuticals (IONS) United States $7.727B 0.00
Neurocrine Biosciences (NBIX) United States $6.695B 1476.60
Nektar Therapeutics (NKTR) United States $6.399B 9.17
Catalent (CTLT) United States $5.308B 22.26
Sage Therapeutics (SAGE) United States $5.188B 0.00
Impax Laboratories (AMRX) United States $4.950B 26.32
United Therapeutics (UTHR) United States $4.882B 7.98
Loxo Oncology (LOXO) United States $4.269B 0.00
TESARO (TSRO) United States $4.091B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.538B 13.10
FibroGen (FGEN) United States $3.456B 0.00
USANA Health Sciences (USNA) United States $2.989B 25.44
Endo (ENDP) Ireland $2.517B 3.86
Xencor (XNCR) United States $2.148B 0.00
Heron Therapeutics (HRTX) United States $2.082B 0.00
Corcept Therapeutics (CORT) United States $1.969B 28.90
Endocyte (ECYT) United States $1.958B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.943B 262.50
Aerie Pharmaceuticals (AERI) United States $1.848B 0.00
Zogenix (ZGNX) United States $1.845B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.778B 0.00
PTC Therapeutics (PTCT) United States $1.760B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.738B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.557B 0.00
Esperion Therapeutics (ESPR) United States $1.478B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.452B 20.43
Portola Pharmaceuticals (PTLA) United States $1.433B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.401B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.355B 0.00
Tricida (TCDA) United States $1.326B 0.00
TherapeuticsMD (TXMD) United States $0.999B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.980B 0.00
ImmunoGen (IMGN) United States $0.810B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.805B 0.00
Radius Health (RDUS) United States $0.777B 0.00
Karyopharm Therapeutics (KPTI) United States $0.634B 0.00
Collegium Pharmaceutical (COLL) United States $0.617B 0.00
Forty Seven (FTSV) United States $0.607B 0.00
Flexion Therapeutics (FLXN) United States $0.544B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.528B 0.00
ChemoCentryx (CCXI) United States $0.526B 41.64
Siga Technologies (SIGA) United States $0.513B 0.00
Akebia Therapeutics (AKBA) United States $0.510B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.475B 0.00
GlycoMimetics (GLYC) United States $0.465B 0.00
Dermira (DERM) United States $0.455B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.448B 26.41
Dova Pharmaceuticals (DOVA) United States $0.443B 0.00
Tyme Technologies (TYME) United States $0.434B 0.00
Odonate Therapeutics (ODT) United States $0.423B 0.00
Xeris Pharmaceuticals (XERS) United States $0.422B 0.00
KalVista Pharmaceuticals (KALV) United States $0.412B 0.00
CASI Pharmaceuticals (CASI) United States $0.411B 0.00
Translate Bio (TBIO) United States $0.406B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.393B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.384B 0.00
ArQule (ARQL) United States $0.375B 0.00
Majesco Entertainment (PTE) United States $0.347B 0.00
Aclaris Therapeutics (ACRS) United States $0.335B 0.00
Tapimmune (MRKR) United States $0.326B 0.00
Concert Pharmaceuticals (CNCE) United States $0.319B 0.00
Aratana Therapeutics (PETX) United States $0.310B 0.00
Minerva Neurosciences (NERV) United States $0.307B 0.00
OptiNose (OPTN) United States $0.294B 0.00
Mast Therapeutics (SVRA) United States $0.274B 0.00
Depomed (ASRT) United States $0.274B 10.19
Verrica Pharmaceuticals (VRCA) United States $0.266B 0.00
Aldeyra Therapeutics (ALDX) United States $0.256B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.247B 0.00
IMV INC (IMV) Canada $0.239B 0.00
Affimed (AFMD) Germany $0.238B 0.00
Ocular Therapeutix (OCUL) United States $0.235B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.217B 0.00
Galectin Therapeutics (GALT) United States $0.216B 0.00
Lannett Co Inc (LCI) United States $0.207B 1.79
Zafgen (ZFGN) United States $0.202B 0.00
Opexa Therapeutics (ACER) United States $0.199B 0.00
Aquestive Therapeutics (AQST) United States $0.197B 0.00
TAIWAN LIPOSOME (TLC) Taiwan $0.189B 0.00
Calithera Biosciences (CALA) United States $0.186B 0.00
MEI Pharma (MEIP) United States $0.183B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.182B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.171B 0.00
Nature's Sunshine Products (NATR) United States $0.170B 0.00
Recro Pharma (REPH) United States $0.167B 0.00
Molecular Templates (MTEM) United States $0.166B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.163B 0.00
Neon Therapeutics (NTGN) United States $0.160B 0.00
Ardelyx (ARDX) United States $0.150B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.149B 0.00
Redhill Biopharma (RDHL) Israel $0.148B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.141B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.141B 0.00
ElectroCore (ECOR) United States $0.139B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.138B 0.00
MediWound (MDWD) Israel $0.134B 0.00
Cardiome Pharma (CORV) Canada $0.132B 0.00
DURECT (DRRX) United States $0.123B 0.00
Jounce Therapeutics (JNCE) United States $0.122B 0.00
Adherex Technologies (FENC) United States $0.119B 0.00
ProNAi Therapeutics (SRRA) Canada $0.117B 0.00
Rafael Holdings (RFL) United States $0.114B 0.00
Champions Oncology (CSBR) United States $0.113B 0.00
Iterum Therapeutics (ITRM) Ireland $0.103B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.098B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.094B 0.00
Immune Design (IMDZ) United States $0.093B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.089B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.086B 0.00
CTI BioPharma (CTIC) United States $0.086B 0.00
Achaogen (AKAO) United States $0.083B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.081B 0.00
Natural Alternatives (NAII) United States $0.075B 7.37
Melinta Therapeutics (MLNT) United States $0.074B 0.00
Otonomy (OTIC) United States $0.073B 0.00
KemPharm (KMPH) United States $0.072B 0.00
Infinity Pharmaceuticals (INFI) United States $0.071B 0.00
BioLineRx (BLRX) Israel $0.069B 0.00
Nivalis Therapeutics (ALPN) United States $0.066B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.061B 38.10
Neos Therapeutics (NEOS) United States $0.061B 0.00
Avenue Therapeutics (ATXI) United States $0.053B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.052B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.051B 0.00
Genocea Biosciences (GNCA) United States $0.051B 0.00
Mannatechorporated (MTEX) United States $0.047B 0.00
Forward Pharma (FWP) Denmark $0.047B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.040B 0.00
Novan (NOVN) United States $0.039B 0.00
ProPhase Labs (PRPH) United States $0.036B 4.08
Capnia (SLNO) United States $0.034B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.034B 0.00
Heat Biologics (HTBX) United States $0.031B 0.00
Lipocine (LPCN) United States $0.031B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.030B 0.00
Trillium Therapeutics (TRIL) Canada $0.028B 0.00
IsoRay (ISR) United States $0.027B 0.00
PharmAthene (ALT) United States $0.027B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.026B 0.00
Can-Fite Biopharma (CANF) Israel $0.026B 0.00
SCYNEXIS (SCYX) United States $0.026B 0.00
Xenetic Biosciences (XBIO) United States $0.025B 0.00
NanoViricides (NNVC) United States $0.023B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.022B 0.00
Biomerica (BMRA) United States $0.022B 0.00
Cyanotech (CYAN) United States $0.022B 0.00
Jaguar Animal Health (JAGX) United States $0.021B 0.00
HANCOCK JAFFE (HJLI) United States $0.021B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.021B 0.00
Aviragen Therapeutics (VXRT) United States $0.020B 0.00
Citius Pharmaceuticals (CTXR) United States $0.019B 0.00
Onconova Therapeutics (ONTX) United States $0.019B 0.00
Pain Therapeutics (PTIE) United States $0.019B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.018B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.017B 6.25
ESSA Pharma (EPIX) Canada $0.016B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.013B 0.00
Shineco (TYHT) China $0.013B 1.45
DelMar Pharmaceuticals (DMPI) Canada $0.010B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.009B 0.00
Skyline Medical (AIPT) United States $0.009B 0.00
Aradigm (ARDM) United States $0.008B 0.00
Apricus Biosciences (APRI) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.008B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Midatech Pharma (MTP) United Kingdom $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.004B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.004B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.003B 0.00
Intellipharmaceutics (IPCI) Canada $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
AGEX THERAPEUTC (AGE) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00